

Metabolic disorders About theme
The mission of our Theme is to deliver personalized, predictive, preventive and Participatory (P4) medicine to our metabolic patients, i.e. to achieve precise and timely diagnoses, provide personalized treatment, take preventive health care measures for metabolic disease patients by an orchestrated multidisciplinary approach. read moreNews, events, impact and organization
-
Hans Spelbrink is beneficiary of the MITGEST Doctoral Networkwhich receives 2.6 million euros funding (PhD positions available)27 September 2022
-
Towards a better understanding of Leigh Syndrome pathology and interventionpublished in Brain8 December 2021
-
New genetic defect links cell biology and protein glycosylation10 November 2021
Answers in Dutch
Information on our research can also be found in Dutch on the Nationale Wetenschapsagenda website. The information here answers questions asked by Dutch citizens.
visit websiteSocietal impact
- Outreach activities for patients with mitochondrial diseases and other stakeholders
- The successful road to development of drug candidate KH176, and beyond
- Complex I assembly pathway elucidation
- Mitochondrial drug developed at Radboudumc is safe in healthy male volunteers
- Quantitative morphofunctional analysis of mitochondria
- Diabetes research at Radboudumc
- Psychological aspects of mitochondrial disorders


Center of clinical expertise Mitochondrial Medicine
The RCMM is an international expert center for clinical care, diagnostics and research for patients with or suspected of having a mitochondrial energy disorder.
see page (Dutch)